Protease-Activated Receptors – Key Regulators of Inflammatory Bowel Diseases Progression
Damian Jacenik,1 Jakub Fichna,2 Ewa Małecka-Wojciesko,3 Anna Mokrowiecka3 1Department of Cytobiochemistry, Faculty of Biology and Environmental Protection, University of Lodz, Lodz, Poland; 2Department of Biochemistry, Faculty of Medicine, Medical University of Lodz, Lodz, Poland; 3Depart...
Saved in:
Main Authors: | Jacenik D (Author), Fichna J (Author), Małecka-Wojciesko E (Author), Mokrowiecka A (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2021-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Peroxisome Proliferator-Activated Receptors: Experimental Targeting for the Treatment of Inflammatory Bowel Diseases
by: Juan Decara, et al.
Published: (2020) -
Nuclear Receptors in the Pathogenesis and Management of Inflammatory Bowel Disease
by: Longgui Ning, et al.
Published: (2019) -
Oxidative Stress Does Not Influence Subjective Pain Sensation in Inflammatory Bowel Disease Patients
by: Anna Krystyna Zielińska, et al.
Published: (2021) -
New Insights Into the Epigenetic Regulation of Inflammatory Bowel Disease
by: Jing Xu, et al.
Published: (2022) -
Time to diagnosis in paediatric inflammatory bowel disease: Key points for an early diagnosis
by: Javier Martín-, et al.
Published: (2020)